Crucial Protein Discovered to be Beneficial or Detrimental for Cancer Patients depending on Cancer Type
Professor Katrin Mani's team found that the protein Glypican-4 tracks with worse outcomes in glioblastoma but better survival in lung adenocarcinoma, and switching it off had opposite effects.